University of Hawaii Cancer Center Receives $3 Million R01 NCI Grant for Bladder Cancer Research



Charles Rosser, MD, MBA, FACS

Charles Rosser, MD, MBA, FACS

Charles Rosser, MD, MBA, FACS, Professor and Director of the Clinical Trials Office and Director of the Clinical and Translational Research Program at the University of Hawaii Cancer Center, received a 5-year National Cancer Institute (NCI) R01 grant worth more than $3 million. The grant is for research on a urine-based bladder cancer detection test that may determine those at risk for the disease.

The test could help identify those who may require more invasive evaluation and tests and reduce the need for uncomfortable and expensive examinations. The test is expected to be more reliable and accurate than other tests for patients who have a history of bladder cancer and are on lifetime surveillance, as well as for patients with obvious blood in their urine.

The grant for the study, “Multiplexed Protein Biomarker-Based Assay for the Detection of Bladder Cancer,” will provide funding to perform a clinical trial to determine the accuracy of the test. Funds will be used to perform the trial in Hawaii and University of Texas Southwestern in Dallas. Fred Hutchinson Cancer Center will help collect and analyze the data. ■



Advertisement

Advertisement



Advertisement

click me